Loading ...

Fast insight into nanotechnology

Access easily searchable nanoscience data, synthesis methods and literature

doxorubicin-polylactide/poly(ethylene glycol)-b-polylactide-pamidronate nanoparticles

Based on

1 Articles
2016 Most recent source

Composition

Image only illustrates the order and placement of components as described in literature.

1

doxorubicin-polylactide/poly(ethylene glycol)-b-polylactide-pamidronate

Doxo-PLA/PLA-PEG-Pam
Type Complex Compound
Formula
Role raw materials

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
colloidal stability

More information/entries available to subscribers only.

Or, view sample content

Applications

Area Application Nanomaterial Variant Source
medicine/veterinary

More information available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
dynamic light scattering

More information/entries available to subscribers only.

Or, view sample content

Biological effects

Preparation

Method 1

Type: Physical formation
Source:
Starting materials
  • doxorubicin-polylactide
  • pamidronate-conjugated poly(ethylene glycol)-b-polylactide
  1. NwAUP7vnXTxi
Product

doxorubicin-polylactide/poly(ethylene glycol)-b-polylactide-pamidronate nanoparticles

Size: not specified

Medium/Support: none

Method 2

Type: Physical formation
Source:
Product

doxorubicin-polylactide/poly(ethylene glycol)-b-polylactide-pamidronate nanoparticles

Hydrodynamic diameter: 70 - 140 nm

Medium: water

Support: none

References

Full content is available to subscribers only

To view content please choose from the following:

We use cookies to improve your experience with our site. More information

Sign up for a free trial